PipelinePharma Logo

Generics 52

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Irinotecan manufacturers

52 products found

Filters

Filters

Filters , active

Country of origin : Kazakshan

Clear all

52 products found

irinotecan

Vials 40 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
South Africa
Available for
Technology transfer
MAs available in
Canada
Comments
Not available for Licensing and distribution, only for Technology Transfer
Manufacturer #6301
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, MENA, LATAM, and NA for 20+ years. Main therapeutic area include oncology and urology. The company's production lines are GMP-compliant. The main dosage forms includes injectable. The company possesses subsidiaries in LATAM

Manufacturer usually replies in 7 days

irinotecan

Concentrate for solution for infusion 40 mg/2 ml, 100 mg/5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Unavailable markets
Austria , Belgium , Bulgaria , Croatia , Cyprus , Czech Republic , Denmark , Estonia , Finland , France , Germany , Greece , Hungary , Iceland , Ireland , Italy , Kosovo , Latvia , Lithuania , Malta , Netherlands , Norway , Poland , Portugal , Romania , Slovakia , Spain , Sweden , United Kingdom , Vietnam
Available for
Distribution only
Comments
Product is not available for Europe
Manufacturer #298
This company is a global pharmaceutical and commercial organization that has been operating for over five decades. It specializes in injectable and prescription drug products, medical devices, and food supplements. Their manufacturing facilities are EU and US GMP approved. They have a strong presence in international markets, especially in Europe, North America, and Asia. The company also prides itself on its commitment to research and development of new products, particularly in the field of monoclonal antibodies. This commitment has earned them recognition and awards for their innovation and manufacturing excellence.

Manufacturer usually replies in 9 days

irinotecan

Injection 4.3 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA, Saudi Arabia, South Korea, Libya, Turkey, LY, SA, KR, TR
Comments
Dossier Status: Upon request. Reference product: Onivyde
Manufacturer #11907
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines include Rx, OTC, medical devices, and cosmetics. The company's production lines are EU GMP-compliant. The company owns branches in the EU, North America, and Africa.

Manufacturer usually replies in 39 days

Want to see all 52 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the Irinotecan drug?

Irinotecan is an antineoplastic enzyme inhibitor; it reduces the spread of the cancer cells in the body. It is a medication used to treat colon cancer and small cell lung cancer. Irinotecan is usually administered during chemotherapy as a single agent or in combination with other drugs.
The FDA, in the US, approved the medical use of Irinotecan medication in 1996. Irinotecan is on the WHO's List of Essential Medicines, the safest and most effective medicines needed in a health system. The natural compound camptothecin found in the Chineses ornamental tree Camptotheca acuminata is used to make the Irinotecan medication.

Irinotecan manufacturers and wholesalers:

The US brand name for Irinotecan is Camptosar. Irinotecan is a globally found drug. Among all the manufacturers, we can list some, such as Pfizer Inc, Accord Healthcare Inc, Actavis Totowa Llc, Teva Parenteral Medicines Inc, and Watson Laboratories Inc.
Irinotecan suppliers market it in the forms of 20 mg solutions or solutions for injection. Under the generic names, for injection of Irinotecan, the drug can be found at different dosages: 40 mg/2 ml; 100 mg/5 ml; 300 mg/15 ml; 500 mg/25 ml. For Camptosar, the solution for injection can be marketed in the strength of 40 mg/2 ml; 100 mg/5 ml; 300 mg/15 ml.

Irinotecan for sales:

On the US market, the price of Irinotecan can vary if it is sold under the generic name or the brand name. For 20mg/ml of an intravenous solution of Irinotecan, it can cost from $17 to $202 for 2ml, about $19.60 for 5ml, and about $131.30 for 25ml. The prices for Irinotecan under the brand name Camptosar are slightly different. For Camptosar 20 mg/ml intravenous solution, 2 ml costs about $35.60, 5 ml about $48.48, and for 15ml, it costs about $126.43
As Irinotecan is a globally found drug, you may encounter fraudulent online websites that will want to sell Irinotecan with some risks for you and your clients. By using Pipelinepharma B2B marketplace, you avoid time-consuming sourcing, and you directly find qualified sellers of Irinotecan. Those manufacturers and distributors have been through quality control procedures to ensure they were qualified partners. On the online platform, Irinotecan is mostly available from the EU, India, Argentina, Turkey, China, and Ukraine. Thanks to the intuitive online marketplace, you will find Irinotecan and many other drugs quickly and efficiently. Placing an order has never been easier than with Pipelinepharma. Let us connect you with Irinotecan. Manufacturers and distributors.

How to use Irinotecan drugs?

Using Irinotecan medication as a single agent for the treatment of colorectal cancer, an adult should be administered 125 mg/m2 IV over 90 minutes on Days 1, 8, 15, and 22 then 2-week rest or 350 mg/m2 IV over 90 minutes on Day 1 every three weeks.
Taking Irinotecan can cause some side effects, the most common ones are severe diarrhea, black, tarry stools, blood in the urine or stools, blurred vision, changes in skin color, and chest pain or discomfort.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.